Evidence map›Paper›PMID 24098285›Full record

ArticleFrontiers in physiology2013

Emerging key roles for P2X receptors in the kidney.

R E Birch, E M Schwiebert, C M Peppiatt-Wildman, S S Wildman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Knockout ofAmerican journal of physiology. Renal physiology · 2019
    Article
  6. Article
  7. Calcium-permeable ion channels in the kidney.American journal of physiology. Renal physiology · 2016
    Review
  8. Review
  9. The dark side of extracellular ATP in kidney diseases.Journal of the American Society of Nephrology : JASN · 2015
    Review
  10. Review
  11. P2X7 receptor inhibition protects against ischemic acute kidney injury in mice.American journal of physiology. Cell physiology · 2015
    Article
  12. Article
  13. Review
  14. Inhibition of ENaC by endothelin-1.Vitamins and hormones · 2015
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

R E BirchMedway School of Pharmacy, The Universities of Kent and Greenwich Kent, UK.
E M Schwiebert
C M Peppiatt-Wildman
S S Wildman
DiscoveryBioMed (United States) · USMedway School of Pharmacy · GBUniversity of Kent · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

P2X ionotropic non-selective cation channels are expressed throughout the kidney and are activated in a paracrine or autocrine manner following the binding of extracellular ATP and related extracellular nucleotides. Whilst there is a wealth of literature describing a regulatory role of P2 receptors (P2R) in the kidney, there are significantly less data on the regulatory role of P2X receptors (P2XR) compared with that described for metabotropic P2Y. Much of the historical literature describing a role for P2XR in the kidney has focused heavily on the role of P2X1R in the autoregulation of renal blood flow. More recently, however, there has been a plethora of manuscripts providing compelling evidence for additional roles for P2XR in both kidney health and disease. This review summarizes the current evidence for the involvement of P2XR in the regulation of renal tubular and vascular function, and highlights the novel data describing their putative roles in regulating physiological and pathophysiological processes in the kidney.

Indexed as

inborn errorskidneyP2 receptorsP2X7 receptorP2X receptorpathologyrenal circulationrenal tubular transport

Identifiers

PMID24098285
PMCPMC3785026
OpenAlexW2055970849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.